Ronald Kamdem
Stock Analyst at Morgan Stanley
(0)
# 3831
Out of 5,291 analysts
198
Total ratings
48.96%
Success rate
-3.92%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
American Healthcare ... | Maintains: Overweight | 36 37 | 30.38 | 21.79% | 4 | Mar 25, 2025 | |
Paramount Group | Maintains: Equal-Weight | 5 4 | 4.25 | -5.88% | 6 | Mar 18, 2025 | |
Hudson Pacific Prope... | Maintains: Underweight | 3 3 | 2.98 | -24.5% | 10 | Mar 18, 2025 | |
Vornado Realty | Maintains: Equal-Weight | 26 28 | 36.73 | -23.77% | 7 | Mar 14, 2025 | |
CBRE Group | Maintains: Overweight | 160 165 | 129.38 | 27.53% | 3 | Feb 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 27 | 23.87 | 13.11% | 1 | Jan 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 53 53 | 50.4 | 5.16% | 4 | Jan 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 20 | 17.09 | 17.03% | 1 | Jan 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 23 22 | 12.89 | 70.67% | 2 | Jan 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 25 | 22.79 | 9.7% | 1 | Dec 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 293 315 | 294.23 | 7.06% | 17 | Oct 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 100 | 59.01 | 69.46% | 1 | Aug 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 132 133 | 110.34 | 20.54% | 6 | Aug 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Equal-Weight | 62 | 56.6 | 9.54% | 7 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 103 108 | 153.36 | -29.9% | 5 | Jul 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 33 33 | 31.99 | 3.16% | 4 | Jun 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 9 7 | 8.56 | -18.22% | 1 | Apr 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 2 2 | 0.48 | 233.33% | 15 | Mar 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 18 21 | 29.2 | -28.08% | 10 | Mar 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 143 145 | 164.19 | -11.69% | 3 | Feb 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 14 18 | 18.88 | -4.66% | 1 | Dec 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 62 75 | 72.84 | 2.97% | 1 | Dec 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 115 150 | 145.38 | 3.18% | 20 | Dec 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 42 32 | 38.74 | -17.4% | 20 | Sep 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 45 47 | 68.74 | -31.63% | 3 | Sep 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 40 40 | n/a | n/a | 5 | Jul 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 30 24 | 16.68 | 40.89% | 7 | Jul 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 38 35 | 57.53 | -39.16% | 5 | Mar 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 68 67 | 67.66 | -0.98% | 6 | Mar 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 20 19 | 16.96 | 12.03% | 6 | Dec 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 25 26 | n/a | n/a | 5 | Nov 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 45 46 | 42.05 | 9.39% | 6 | Nov 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 77 73 | 76.55 | -4.64% | 3 | Nov 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 195 150 | 176.12 | -14.83% | 1 | Oct 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 41 48 | n/a | n/a | 1 | Jun 3, 2021 |